Prolor Biotech Tumbles Most in Month After Offering Announcement

Prolor Biotech Inc. (PBTH) declined the most in more than a month after the developer of therapeutic proteins priced an offering of 6.5 million shares at $5 each.

The shares tumbled 6.1 percent, the most since April 8, to 20.20 shekels at 10:27 a.m. in Tel Aviv. The U.S.-traded shares declined 7.9 percent to $5.24 on May 11 when the company announced the pricing.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.